|
π
|
Age-related clonal hematopoiesis associated with adverse outcomes.
34 auth.
S. Jaiswal,
P. Fontanillas,
J. Flannick,
A. Manning,
Peter V. Grauman,
B. Mar,
R. C. Lindsley,
C. Mermel,
N. Burtt,
A. Chavez,
J. Higgins,
V. Moltchanov,
F. Kuo,
Michael J. Kluk,
B. Henderson,
...
L. Kinnunen,
H. Koistinen,
C. Ladenvall,
G. Getz,
A. Correa,
B. Banahan,
S. Gabriel,
S. Kathiresan,
H. Stringham,
M. McCarthy,
M. Boehnke,
J. Tuomilehto,
C. Haiman,
L. Groop,
G. Atzmon,
James G. Wilson,
D. Neuberg,
D. Altshuler,
B. Ebert
|
11 |
2014 |
11
π
|
|
π
|
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
19 auth.
R. C. Lindsley,
B. Mar,
E. Mazzola,
Peter V. Grauman,
S. Shareef,
Steven L. Allen,
A. Pigneux,
M. Wetzler,
Robert K. Stuart,
H. Erba,
...
Lloyd E. Damon,
B. Powell,
Neal Lindeman,
D. Steensma,
M. Wadleigh,
D. DeAngelo,
D. Neuberg,
Richard M Stone,
Benjamin L Ebert
|
9 |
2015 |
9
π
|
|
π
|
Prognostic Mutations in Myelodysplastic Syndrome after StemβCell Transplantation
17 auth.
Coleman Lindsley,
W. Saber,
B. Mar,
R. Redd,
Tao Wang,
M. Haagenson,
Peter V. Grauman,
Zhen-Huan Hu,
S. Spellman,
Stephanie J. Lee,
...
M. Verneris,
K. Hsu,
K. Fleischhauer,
C. Cutler,
J. Antin,
D. Neuberg,
B. Ebert
|
9 |
2017 |
9
π
|
|
π
|
Somatic mutations predict poor outcome in patients with myelodysplastic syndrome after hematopoietic stem-cell transplantation.
18 auth.
R. Bejar,
K. Stevenson,
B. Caughey,
R. C. Lindsley,
B. Mar,
P. Stojanov,
G. Getz,
D. Steensma,
J. Ritz,
R. Soiffer,
...
J. Antin,
E. Alyea,
P. Armand,
V. Ho,
J. Koreth,
D. Neuberg,
C. Cutler,
B. Ebert
|
8 |
2014 |
8
π
|
|
π
|
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma.
29 auth.
C. Gibson,
R. C. Lindsley,
V. Tchekmedyian,
B. Mar,
Jiantao Shi,
S. Jaiswal,
A. Bosworth,
L. Francisco,
Jianbo He,
A. Bansal,
E. Morgan,
A. LaCasce,
A. Freedman,
D. Fisher,
E. Jacobsen,
...
P. Armand,
E. Alyea,
J. Koreth,
V. Ho,
R. Soiffer,
J. Antin,
J. Ritz,
S. Nikiforow,
S. Forman,
F. Michor,
D. Neuberg,
R. Bhatia,
S. Bhatia,
B. Ebert
|
8 |
2017 |
8
π
|
|
π
|
CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia
22 auth.
S. Buonamici,
Thomas Trimarchi,
M. G. Ruocco,
Linsey B. Reavie,
S. Cathelin,
B. Mar,
A. Klinakis,
Yevgeniy Lukyanov,
Jen-Chieh Tseng,
F. Εen,
...
E. Gehrie,
Mengling Li,
E. Newcomb,
J. Zavadil,
D. Meruelo,
M. Lipp,
S. Ibrahim,
A. Efstratiadis,
D. Zagzag,
J. Bromberg,
Michael Loran Dustin,
I. Aifantis
|
8 |
2009 |
8
π
|
|
π¦
|
Mutations in epigenetic regulators including SETD2 are gained during relapse in pediatric acute lymphoblastic leukemia
14 auth.
B. Mar,
L. Bullinger,
Kathleen M. McLean,
Peter V. Grauman,
M. Harris,
K. Stevenson,
D. Neuberg,
A. Sinha,
S. Sallan,
L. Silverman,
...
A. Kung,
L. L. Nigro,
B. Ebert,
S. Armstrong
|
7 |
2014 |
7
π¦
|
|
π
|
PPM1D-truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells.
18 auth.
J. Kahn,
P. Miller,
A. Silver,
R. Sellar,
Shruti Bhatt,
C. Gibson,
M. McConkey,
Dylan N. Adams,
B. Mar,
P. Mertins,
...
Shaunt Fereshetian,
Karsten Krug,
Haoling Zhu,
A. Letai,
S. Carr,
John G Doench,
S. Jaiswal,
B. Ebert
|
7 |
2018 |
7
π
|
|
π¦
|
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia.
16 auth.
B. Mar,
S. H. Chu,
J. Kahn,
J. Kahn,
A. Krivtsov,
R. Koche,
Cecilia Castellano,
Jacob L Kotlier,
Rebecca L. Zon,
M. McConkey,
...
Jonathan R Chabon,
Ryan J Chappell,
Peter V. Grauman,
J. Hsieh,
S. Armstrong,
B. Ebert
|
6 |
2017 |
6
π¦
|
|
π
|
Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial
18 auth.
D. DeAngelo,
D. Radia,
T. George,
W. Robinson,
A. Quiery,
M. Drummond,
P. Bose,
E. Hexner,
E. Winton,
H. Horny,
...
M. Tugnait,
O. Schmidt-Kittler,
E. Evans,
Hui-Min Lin,
B. Mar,
S. Verstovsek,
M. Deininger,
J. Gotlib
|
6 |
2021 |
6
π
|
|
π
|
A novel nuclear protein, 5qNCA (LOC51780) is a candidate for the myeloid leukemia tumor suppressor gene on chromosome 5 band q31
11 auth.
Zhenbo Hu,
I. Gomes,
S. Horrigan,
J. Kravarusic,
B. Mar,
Z. Arbieva,
...
B. Chyna,
N. Fulton,
S. Edassery,
A. Raza,
C. Westbrook
|
6 |
2001 |
6
π
|
|
π
|
Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial
24 auth.
J. Gotlib,
A. Reiter,
D. Radia,
M. Deininger,
T. George,
J. Panse,
A. Vannucchi,
U. Platzbecker,
I. Alvarez-Twose,
A. Mital,
...
O. Hermine,
I. Dybedal,
E. Hexner,
L. Hicks,
L. Span,
R. Mesa,
P. Bose,
K. Pettit,
M. Heaney,
S. Oh,
J. Sen,
Hui-Min Lin,
B. Mar,
D. DeAngelo
|
6 |
2021 |
6
π
|
